NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SUDEEPPHRM is Bearish ↓ (moderate move); technical trend down-trend; trading at ₹1,323.30 (-0.45% today); overbought (RSI 84).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2025-11-28) |
| Price | ₹1,323.30 |
| Change today | -0.45% |
| RSI (14) | 83.60 |
| Relative volume | 0.73 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹12,863 Cr |
| P/E | 70.34 |
| Cap category | Mid Cap |
| 52-week high | -0.5% away |
| 52-week low | +150.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SUDEEPPHRM (Sudeep Pharma Limited) is Bearish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
SUDEEPPHRM's RSI is overbought (RSI 84). A reading above 70 is typically overbought and below 30 oversold.
SUDEEPPHRM is trading about 0% below its 52-week high and 150% above its 52-week low as of Sep 28 2026, 6:47 PM.
SUDEEPPHRM's market capitalisation is ₹12,863 Cr as of Sep 28 2026, 6:47 PM.
SUDEEPPHRM is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SUDEEPPHRM — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.